Back
Marker Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
MRKR
Marker Therapeutics
Last Price:
2.94
Seasonality Move:
24.89%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.27 | Sell |
| 20-day SMA: | 3.71 | Sell |
| 50-day SMA: | 3.29 | Sell |
| 200-day SMA: | 4 | Sell |
| 8-day EMA: | 3.26 | Sell |
| 20-day EMA: | 3.48 | Sell |
| 50-day EMA: | 3.51 | Sell |
| 200-day EMA: | 3.82 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 39.64 | Sell |
| Chaikin Money Flow: | -29867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.32 - 4.24) | Sell |
| Bollinger Bands (100): | (2.86 - 4.66) | Sell |
Marker Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 2.95 while MRKR 8-day simple moving average is 3.27, which is a Sell signal.
- The stock price of MRKR is 2.95 while Marker Therapeutics 20-day SMA is 3.71, which makes it a Sell.
- Marker Therapeutics 50-day simple moving average is 3.29 while MRKR share price is 2.95, making it a Sell technically.
- MRKR stock price is 2.95 and Marker Therapeutics 200-day simple moving average is 4.00, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a Sell
The current Marker Therapeutics [MRKR] share price is $2.95. The Score for MRKR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
26.34M
Price in USD:
2.95
Share Volume:
41.89K
Marker Therapeutics 52-Week Range
52-Week High:
6.16
52-Week Low:
2.44
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?
The Marker Therapeutics stock price is 2.95 USD today. -
Will MRKR stock go up or go down?
Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Marker Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 2.95 while MRKR 8-day exponential moving average is 3.26, which is a Sell signal.
- The stock price of MRKR is 2.95 while Marker Therapeutics 20-day EMA is 3.48, which makes it a Sell.
- Marker Therapeutics 50-day exponential moving average is 3.51 while MRKR share price is 2.95, making it a Sell technically.
- MRKR stock price is 2.95 and Marker Therapeutics 200-day simple moving average is 3.82, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $1.14 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
- MRKR Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Marker Therapeutics is a Sell
- Marker Therapeutics Relative Strength Index (RSI) is 39.64, which suggest Marker Therapeutics is oversold
- The Bollinger Bands (25) for Marker Therapeutics is (3.32 - 4.24), which suggest Marker Therapeutics is a Sell
- The Bollinger Bands (100) for Marker Therapeutics is (2.86 - 4.66), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.